Diagnostic and Therapeutic Biomarkers for Neurodegeneration
Yusuf Kaan Harmanşa1, Oytun Erbaş1
1ERBAS Institute of Experimental Medicine, Illinois, USA & Gebze, Turkey
Keywords: Amyotrophic lateral sclerosis, Alzheimer's disease, biomarkers, neurodegeneration, Parkinson’s disease, Huntington’s disease
Neurodegeneration is now thought to be an irreversible condition. It is important to have a thorough understanding of these disorders and to take measures and cures if possible before the condition develops. Biomarkers play a critical role in various symptoms. Understanding the mechanisms of diseases can help develop novel biomarkers, which is a crucial step in managing neurodegenerative disorders. This review examined the pathophysiology of neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's, disease, and amyotrophic lateral sclerosis, as well as the biomarkers used to diagnose them.
Cite this article as: Harmanşa YK, Erbaş O. Diagnostic and Therapeutic Biomarkers for Neurodegeneration. JEB Med Sci 2022;3(1):47-53.
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
The authors received no financial support for the research and/or authorship of this article.